More reads
- Merck cyberattack’s $1.3 billion question: Was it an act of war? (Bloomberg)
- As Trump looks overseas for drug pricing ideas, one expert says France has some useful approaches. (STAT Plus)
- FDA nominee clears Senate panel (New York Times)
- China’s CRISPR babies: Read exclusive excerpts from the unseen original research. (MIT Technology Review)
No hay comentarios:
Publicar un comentario